← Leaderboards
Tara Lynn Deans
University Of Utah
$3,873,598
Attributed
$3,873,598
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2018–24$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,873,598 · 3
By mechanism
DP2$2,355,636 · 1
R01$908,586 · 1
R21$609,376 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Patrick G. Beatty$0
- John R Michael$416,620
- Elizabeth Marie Sefton$510,128
- Robert E Marc$15,329,042
- Nirupama Ramkumar$1,744,471
Others in their field
Other Emerging Leaders on “Tissues”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$61,115,130
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,559,980
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Evan Z Macosko · Broad Institute, Inc.$33,867,067
Research focus
TissuesCell TherapyTraffickingBlood PlateletsEngineeringProteinsAngiogenesisSecretory VesiclesInvadedGeneticBlood CirculationMegakaryocytesPhysiological ProcessesPlayApoptosisCytoplasmic GranulesBindingDesignCellsFlexibilityBlood CellsInflammationCoagulation ProcessNext Generation
Grant awards (8)
Synthetic circuits for therapeutic platelet production and immunomodulation$444,081
R01 · FY2024 · EB · contact PI
Synthetic circuits for therapeutic platelet production and immunomodulation$1
R01 · FY2024 · EB · contact PI
Synthetic circuits for therapeutic platelet production and immunomodulation$464,504
R01 · FY2023 · EB · contact PI
Engineered platelets for the targeted destruction of circulating tumor cells - Administrative Supplement$68,136
DP2 · FY2022 · CA · contact PI
Engineering novel delivery systems with synthetic biology$228,750
R21 · FY2020 · EB · contact PI
Engineered platelets for the targeted destruction of circulating tumor cells$2,287,500
DP2 · FY2019 · CA · contact PI
Engineering novel delivery systems with synthetic biology$190,625
R21 · FY2019 · EB · contact PI
Engineering novel delivery systems with synthetic biology$190,001
R21 · FY2018 · EB · contact PI